Fulgent Genetics Revenue Rises 8% to $90.4 Million in Third Quarter
Key Facts
Fulgent Genetics said revenue was $90.4 million in the third quarter of 2026, up about 8% year over year, according to its earnings release published on Nov. 5. The results showed the company remained loss-making during the period, posting a GAAP loss of $13.2 million. The loss on that basis was $0.48 per share. The non-GAAP loss was $2.4 million, or $0.09 per share. The figures put revenue growth alongside continued losses, with a clear difference between the reported loss and the non-GAAP measure.
The company said Chief Financial Officer Paul Kim linked the quarter’s results to improved collection rates. Kim said, "We are pleased with what we achieved in the third quarter, driven by improved collection rates." The company also said it had made progress in addressing a billing system issue. This means collections and billing were among the operational factors the company discussed in its earnings presentation. It added that it was confident in its outlook for the rest of the year, according to the earnings release.
For year-end, Fulgent forecast about $630 million in cash, restricted cash and marketable securities at the end of 2026. The estimate includes $64.1 million that the company said it had used for its share repurchase program through Sept. 30. The forecast combines cash, restricted cash and marketable securities, while the disclosure specifies cumulative cash used for repurchases through the end of September. The company thus provided an estimate of the level of these financial resources at the end of the fiscal year. The disclosure provided no other figure for comparison with this estimate.
The company announced on Oct. 15 that it would publish its third-quarter results after the market close on Nov. 5. In the same announcement, it scheduled an investor call for 4:30 p.m. Eastern time on the day the results were published. The results were announced on the schedule the company had previously set. Available trading data show that FLGT shares closed at $19.68 on Nov. 4. That close was from the session before the results were published and does not reflect the stock’s movement after the announcement.